Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer

NCT04946370 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: 225Ac-J591
DRUG: Pembrolizumab
DRUG: Androgen receptor inhibitor
DIAGNOSTIC_TEST: 68Ga-PSMA-11

Sponsor

Weill Medical College of Cornell University

Collaborators

United States Department of Defense
Merck Sharp & Dohme LLC